SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-07-270378
Filing Date
2007-12-21
Accepted
2007-12-21 15:48:06
Documents
4
Period of Report
2008-01-28
Effectiveness Date
2007-12-21

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 501168
2 GRAPHIC g13934g12c39.jpg GRAPHIC 9412
3 GRAPHIC g13934g37r97.jpg GRAPHIC 10333
4 GRAPHIC g13934g97z57.jpg GRAPHIC 7065
  Complete submission text file 0001193125-07-270378.txt   540002
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12465 | Film No.: 071323094
SIC: 2834 Pharmaceutical Preparations